Abstract
Disclosed herein are compounds that target SMARCA2, SMARCA4 or BRM, causing their degradation. Also disclosed herein are compositions and methods of use in treating associated disorders and disease.
Full Text
What is claimed is:
Disclosed herein are compounds that target SMARCA2, SMARCA4 or BRM, causing their degradation. Also disclosed herein are compositions and methods of use in treating associated disorders and disease.
Timeline
Filed
03/12/2026Published
07/16/2026Granted
Not AvailableIPC Codes(2)
A61K 47/55:the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
A61K 47/54:the modifying agent being an organic compound